Methyl N-[1-(butylcarbamoyl)benzimidazol-2-yl]carbamate

Methyl N-[1-(butylcarbamoyl)benzimidazol-2-yl]carbamate is a benzimidazole carbamate compound with CAS number 17804-35-2 and molecular formula C14H18N4O3. This organic substance has a molecular weight of 290.32 g/mol and belongs to the carbamate family. It is classified as a hazardous chemical with multiple health and environmental concerns, requiring careful handling and appropriate safety measures in industrial applications.

Methyl N-[1-(butylcarbamoyl)benzimidazol-2-yl]carbamate is a solid organic compound with a molecular weight of 290.32 g/mol. The substance contains benzimidazole and carbamate functional groups, which influence its chemical behavior and solubility characteristics. As a carbamate derivative, it typically exhibits moderate stability under normal conditions but may be sensitive to extreme pH and temperature conditions. Specific physical properties such as melting point and solubility require laboratory analysis.

Methyl N-[1-(butylcarbamoyl)benzimidazol-2-yl]carbamate is primarily used in specialized industrial applications requiring benzimidazole carbamate chemistry. Its specific molecular structure makes it suitable for pharmaceutical intermediates, agrochemical synthesis, or specialized chemical manufacturing processes. The compound's unique benzimidazole framework combined with carbamate functionality provides specific reactivity patterns valuable in organic synthesis and chemical research applications requiring these particular structural features.

Methyl N-[1-(butylcarbamoyl)benzimidazol-2-yl]carbamate requires strict safety protocols due to its mutagenic, reproductive toxicity, and skin sensitization properties. Personnel must wear appropriate personal protective equipment including chemical-resistant gloves, safety goggles, and respiratory protection. Work should be conducted in well-ventilated areas or under fume extraction systems. Avoid skin contact and inhalation. The substance carries GHS08, GHS07, and GHS09 pictograms indicating serious health and environmental hazards requiring professional handling expertise.

Methyl N-[1-(butylcarbamoyl)benzimidazol-2-yl]carbamate must be stored in tightly sealed containers in a cool, dry, well-ventilated area away from heat sources and incompatible materials. Storage areas should be secured and accessible only to trained personnel due to the substance's mutagenic and reproductive toxicity properties. Containers should be properly labeled with appropriate hazard warnings. Regular inspection of storage containers is essential to prevent leaks or contamination, particularly given its aquatic toxicity classification.

Immediate medical attention is required for any exposure to methyl N-[1-(butylcarbamoyl)benzimidazol-2-yl]carbamate due to its serious health hazards. For skin contact, remove contaminated clothing and rinse thoroughly with water for at least 15 minutes. If inhaled, move to fresh air immediately and seek medical care. For eye contact, flush with clean water continuously and get immediate medical attention. Do not induce vomiting if ingested. Contact emergency services and provide the safety data sheet to medical personnel.

Methyl N-[1-(butylcarbamoyl)benzimidazol-2-yl]carbamate requires disposal as hazardous waste through licensed waste management companies due to its mutagenic, reproductive, and aquatic toxicity properties. The substance cannot be disposed of in regular waste streams or sewage systems. Disposal must comply with local, national, and EU waste regulations including the Waste Framework Directive. Empty containers must also be treated as hazardous waste. Documentation and waste tracking requirements must be followed throughout the disposal process.

Methyl N-[1-(butylcarbamoyl)benzimidazol-2-yl]carbamate is classified as ADR Class 9 (Miscellaneous Dangerous Goods), Packing Group III for transportation purposes. This classification requires specific packaging, labeling, and documentation according to ADR regulations. Transport must be conducted by qualified carriers with appropriate training and equipment. Packages must display proper shipping names, UN numbers, and hazard labels. Emergency response information must accompany shipments, and drivers must possess ADR certification for Class 9 materials.

Methyl N-[1-(butylcarbamoyl)benzimidazol-2-yl]carbamate is subject to multiple European regulations including REACH registration requirements and CLP classification as Muta. 1B, Repr. 1B, and other hazard categories. While not currently listed as a Substance of Very High Concern (SVHC), its mutagenic and reproductive toxicity properties may trigger authorization requirements. Users must comply with occupational exposure limits, environmental discharge restrictions, and worker protection regulations. Industrial users may require specific permits and safety assessments.

Methyl N-[1-(butylcarbamoyl)benzimidazol-2-yl]carbamate is available through OYSI, a specialized European distributor of technical chemicals. OYSI provides this specialized benzimidazole carbamate compound to qualified industrial customers across Europe with appropriate handling capabilities and regulatory compliance. Due to the substance's hazardous properties and regulatory requirements, purchases are restricted to professional users with demonstrated expertise in handling mutagenic and reproductive toxicants. Contact OYSI directly for availability and technical specifications.